Systematic review of 19 observational studies of adults on hydroxychloroquine for rheumatic disease: pooled retinopathy prevalence 5.1%; cumulative incidence 0.1% at 5, 2.6% at 10 and 5.6% at 15 years; risk higher with dose >5 mg/kg, CKD, female sex and Asian ethnicity.
Meta-analysisn = 19 studies
Daftarian et al. Risk of Retinopathy Associated with Long-Term Use of Hydroxychloroquine in Patients with Rheumatic Diseases: A Systematic Review and Meta-Analysis